07 April 2022 | News
Discovery-based pharmaceutical company in Japan leverages Cloudera for greater speed to insights across its research, development, and post-market value chain.
Image credit: shutterstock
Japanese pharmaceutical company Shionogi & Co., Ltd., has selected Cloudera to boost its data analytics capabilities for increased business performance and realize its vision of achieving data-driven innovation.
Through this partnership, Shionogi hopes to democratize access to its vast amounts of data and promote data literacy to accelerate research and product releases.
As a discovery-based pharmaceutical company, Shionogi is focused on researching and developing more effective medications and pharmaceuticals to protect the health and well-being of patients.
The extensive amounts of data that Shionogi generates and relies on reside in silos on varying platforms spread across various locations. To realize its vision of true data-driven innovation, Shionogi required a comprehensive data platform that could quickly aggregate and analyze this data in a secure and governed manner. Democratized accessibility to this data while maintaining data security and data governance was key.
Cloudera worked with Shionogi to upgrade its existing data platform to the Cloudera Data Platform (CDP), a secure, organized platform that is easily integrated into the various other systems used by Shionogi. The company has integrated all of its data silos, with CDP functioning as a consolidated database.